Page last updated: 2024-08-26

olivacine and Neoplasms

olivacine has been researched along with Neoplasms in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (50.00)	2.80

Authors

Authors	Studies
Czwojdziński, E; Gąsiorowski, K; Gębarowski, T; Tylińska, B; Wiatrak, B	1
Cwynar-Zając, Ł; Czyżnikowska, Ż; Dobosz, A; Gębarowski, T; Kuźniarski, A; Spychała, J; Tylińska, B	1
Awada, A; Bleiberg, H; Brillanceau, MH; Calvo, F; De Valeriola, D; Dosquet, C; Eftekhary, P; Gerard, B; Giacchetti, S; Giroux, B; Lucas, C; Marty, M; Piccart, M; Poullain, MG; Soudon, J	1
Berlion, M; Bourhis, J; Eschwege, F; Frascogna, V; Lucas, C; Maggiorella, L; Poullain, MG; Razy, SD	1

Trials

1 trial(s) available for olivacine and Neoplasms

Article	Year
Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedules. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:12 Topics: Adult; Aged; Biological Availability; Carbazoles; Dose-Response Relationship, Drug; Drug Administration Schedule; Ellipticines; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Pyridines; Risk Assessment; Sensitivity and Specificity; Treatment Outcome	2002

Article

Year

Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedules.

Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:12

Topics: Adult; Aged; Biological Availability; Carbazoles; Dose-Response Relationship, Drug; Drug Administration Schedule; Ellipticines; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Pyridines; Risk Assessment; Sensitivity and Specificity; Treatment Outcome

2002

Other Studies

3 other study(ies) available for olivacine and Neoplasms

Article	Year
Lysosomal Exocytosis of Olivacine on the Way to Explain Drug Resistance in Cancer Cells. International journal of molecular sciences, 2022, May-30, Volume: 23, Issue:11 Topics: Antineoplastic Agents; Doxorubicin; Drug Resistance; Ellipticines; Exocytosis; Lysosomes; Neoplasms	2022
Evaluation of Interactions of Selected Olivacine Derivatives with DNA and Topoisomerase II. International journal of molecular sciences, 2021, Aug-06, Volume: 22, Issue:16 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; DNA; DNA Topoisomerases, Type II; Ellipticines; Humans; Molecular Docking Simulation; Neoplasms; Topoisomerase II Inhibitors; Tumor Cells, Cultured	2021
The olivacine S16020 enhances the antitumor effect of ionizing radiation without increasing radio-induced mucositis. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:7 Topics: Animals; Antineoplastic Agents, Phytogenic; Carbazoles; Cell Division; Combined Modality Therapy; Ellipticines; Female; Humans; Mice; Mice, Inbred C57BL; Mice, Nude; Mouth Mucosa; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Pyridines; Radiotherapy; Stomatitis; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2001